Evidence map›Paper›PMID 37963780›Full record

Trial reportJournal of nuclear medicine technology2024

Vapocoolant Analgesia for Breast Lymphoscintigraphy: A Prospective Clinical Trial.

Sanjit O Tewari, Nina Tamirisa, Guofan Xu, Yang Lu

Open access · hybridAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of nuclear medicine technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sanjit O TewariDepartment of Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas; and sanjit.tewari@gmail.com.
Nina TamirisaDepartment of Breast Surgery, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Guofan XuDepartment of Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas; and.
Yang LuDepartment of Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas; and.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast lymphoscintigraphy is commonly performed before initial surgical intervention and surgical staging in the setting of breast cancer. Breast lymphoscintigraphy injections can often be quite painful and are routinely performed without any anesthesia or analgesia, thus representing a significant unmet need for the breast cancer population. Although vapocoolants have been previously available, they have typically been used on intact skin and not been recommended for sterile procedures.

Indexed as

AnalgesiaBreast NeoplasmsLymphoscintigraphyAdultAgedAged, 80 and overFemaleHumansMiddle AgedPainProspective Studiesbreastbreast cancerlymphoscintigraphyoncologyvapocoolant

Identifiers

PMID37963780
PMCPMC11149591
OpenAlexW4388666973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.